Introducing RareCyte, Inc.

Company Overview

RareCyte is an innovative, microenvironment-focused company that has developed technologies and end-to-end integrated platforms to accelerate research in oncology, immuno-oncology, maternal-fetal health, and cell and gene therapy. Trusted as a one-stop resource in spatial transcriptomics and liquid biopsy, RareCyte is widely utilized in research, translational medicine, and clinical institutions. The company’s highly multiplexed fluorescence imaging systems, reagents, and contract services enable researchers to uncover the spatial context of critical biomarkers and develop therapeutics and companion diagnostics through rare cell analysis.

Research Highlights

Here are some featured studies:

Featured Article

Unraveling the Complexity of the Tumor Microenvironment Using RareCyte’s Orion Platform for Multiplex Imaging Technology

Contact Us

For more information about our products and services, please visit yamato-net.co.jp.